SJÖGREN'S SYNDROME
Clinical trials for SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare immune diseases: managed access to VAY736 begins
Disease control AVAILABLEThis program provides access to the drug VAY736 (ianalumab) for patients with serious conditions like primary immune thrombocytopenia or Sjögren's syndrome who have no other treatment options. It is for patients who cannot join a clinical trial. The goal is to offer potential ben…
Matched conditions: SJÖGREN'S SYNDROME
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 10:06 UTC
-
Sjögren's drug safety tracked in long-term extension trial
Disease control Recruiting nowThis study looks at the long-term safety of the drug dazodalibep in people with Sjögren's syndrome. About 844 participants who completed a previous phase 3 study will receive the drug and be monitored for side effects and immune responses. The goal is to see if the drug remains s…
Matched conditions: SJÖGREN'S SYNDROME
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New eye drop could bring relief to Sjögren's dry eye sufferers
Symptom relief Recruiting nowThis study tests a new eye drop (rhPRG4) for people with dry eye caused by Sjögren's syndrome. About 80 adults in Australia will receive either the active drop or a placebo for 28 days. The goal is to see if the drop can reduce eye surface damage and improve comfort, with safety …
Matched conditions: SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: Lubris Bio Pty Ltd • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC